Drug-pathway association prediction: from experimental results to computational models

被引:33
作者
Wang, Chun-Chun [1 ]
Zhao, Yan [1 ]
Chen, Xing [1 ,2 ]
机构
[1] China Univ Min & Technol, Sch Informat & Control Engn, Xuzhou 221116, Jiangsu, Peoples R China
[2] China Univ Min & Technol, Inst Bioinformat, Xuzhou, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
drug; pathway; drug-pathway association prediction; computational models; machine learning; algorithm evaluation; TARGET INTERACTION PREDICTION; INTERACTION NETWORKS; SIGNALING PATHWAY; COMPLEX DISEASES; SMALL MOLECULES; DISCOVERY; TECHNOLOGIES; PHARMACOLOGY; MICRORNAS; INFERENCE;
D O I
10.1093/bib/bbaa061
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Effective drugs are urgently needed to overcome human complex diseases. However, the research and development of novel drug would take long time and cost much money. Traditional drug discovery follows the rule of one drug-one target, while some studies have demonstrated that drugs generally perform their task by affecting related pathway rather than targeting single target. Thus, the new strategy of drug discovery, namely pathway-based drug discovery, have been proposed. Obviously, identifying associations between drugs and pathways plays a key role in the development of pathway-based drug discovery. Revealing the drug-pathway associations by experiment methods would take much time and cost. Therefore, some computational models were established to predict potential drug-pathway associations. In this review, we first introduced the background of drug and the concept of drug-pathway associations. Then, some publicly accessible databases and web servers about drug-pathway associations were listed. Next, we summarized some state-of-the-art computational methods in the past years for inferring drug-pathway associations and divided these methods into three classes, namely Bayesian spare factor-based, matrix decomposition-based and other machine learning methods. In addition, we introduced several evaluation strategies to estimate the predictive performance of various computational models. In the end, we discussed the advantages and limitations of existing computational methods and provided some suggestions about the future directions of the data collection and the calculation models development.
引用
收藏
页数:15
相关论文
共 76 条
[1]   The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts [J].
Abboud, Camille ;
Berman, Ellin ;
Cohen, Adam ;
Cortes, Jorge ;
DeAngelo, Daniel ;
Deininger, Michael ;
Devine, Steven ;
Druker, Brian ;
Fathi, Amir ;
Jabbour, Elias ;
Jagasia, Madan ;
Kantarjian, Hagop ;
Khoury, Jean ;
Laneuville, Pierre ;
Larson, Richard ;
Lipton, Jeffrey ;
Moore, Joseph O. ;
Mughal, Tariq ;
O'Brien, Susan ;
Pinilla-Ibarz, Javier ;
Quintas-Cardama, Alfonso ;
Radich, Jerald ;
Reddy, Vishnu ;
Schiffer, Charles ;
Shah, Neil ;
Shami, Paul ;
Silver, Richard T. ;
Snyder, David ;
Stone, Richard ;
Talpaz, Moshe ;
Tefferi, Ayalew ;
Van Etten, Richard A. ;
Wetzler, Meir ;
Abruzzese, Elisabetta ;
Apperley, Jane ;
Breccia, Massimo ;
Byrne, Jenny ;
Cervantes, Francisco ;
Chelysheva, Ekaterina ;
Clark, R. E. ;
de Lavallade, Hugues ;
Dyagil, Iryna ;
Gambacorti-Passerini, Carlo ;
Goldman, John ;
Haznedaroglu, Ibrahim ;
Hjorth-Hansen, Henrik ;
Holyoake, Tessa ;
Huntly, Brian ;
le Coutre, Philipp ;
Lomaia, Elza .
BLOOD, 2013, 121 (22) :4439-4442
[2]   Targeting the TGFβ signalling pathway in disease [J].
Akhurst, Rosemary J. ;
Hata, Akiko .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (10) :790-811
[3]   Supervised prediction of drug-target interactions using bipartite local models [J].
Bleakley, Kevin ;
Yamanishi, Yoshihiro .
BIOINFORMATICS, 2009, 25 (18) :2397-2403
[4]   Drug target identification using side-effect similarity [J].
Campillos, Monica ;
Kuhn, Michael ;
Gavin, Anne-Claude ;
Jensen, Lars Juhl ;
Bork, Peer .
SCIENCE, 2008, 321 (5886) :263-266
[5]   Pathway Commons, a web resource for biological pathway data [J].
Cerami, Ethan G. ;
Gross, Benjamin E. ;
Demir, Emek ;
Rodchenkov, Igor ;
Babur, Oezguen ;
Anwar, Nadia ;
Schultz, Nikolaus ;
Bader, Gary D. ;
Sander, Chris .
NUCLEIC ACIDS RESEARCH, 2011, 39 :D685-D690
[6]   Systematic Analysis of the Associations between Adverse Drug Reactions and Pathways [J].
Chen, Xiaowen ;
Wang, Yanqiu ;
Wang, Pingping ;
Lian, Baofeng ;
Li, Chunquan ;
Wang, Jing ;
Li, Xia ;
Jiang, Wei .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[7]   MicroRNAs and complex diseases: from experimental results to computational models [J].
Chen, Xing ;
Xie, Di ;
Zhao, Qi ;
You, Zhu-Hong .
BRIEFINGS IN BIOINFORMATICS, 2019, 20 (02) :515-539
[8]   Long non-coding RNAs and complex diseases: from experimental results to computational models [J].
Chen, Xing ;
Yan, Chenggang Clarence ;
Zhang, Xu ;
You, Zhu-Hong .
BRIEFINGS IN BIOINFORMATICS, 2017, 18 (04) :558-576
[9]   A heterogeneous label propagation approach to explore the potential associations between miRNA and disease [J].
Chen, Xing ;
Zhang, De-Hong ;
You, Zhu-Hong .
JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
[10]   MicroRNA-small molecule association identification: from experimental results to computational models [J].
Chen, Xing ;
Guan, Na-Na ;
Sun, Ya-Zhou ;
Li, Jian-Qiang ;
Qu, Jia .
BRIEFINGS IN BIOINFORMATICS, 2020, 21 (01) :47-61